Literature DB >> 1682379

Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane.

L G Byrd1, A H McDonald, L G Gold, M Potter.   

Abstract

Forty to sixty percent of conventionally (CON) raised BALB/cAnPt (BALB/c) mice develop plasmacytomas (PCT) when injected with three 0.5 ml i.p. injections of pristane. When CON-BALB/c mice were converted to specific pathogen free (SPF) status by foster nursing caesarean delivered term mice on C3H/HeN SPF mothers and maintained under strict SPF conditions, less than 5% of the mice developed pristane-induced PCT. FACS analysis of the cellular composition of oil granulomatous tissue revealed a dramatic influx of CD4+ cells in CON mice that was significantly reduced in SPF mice. Moreover, while both CON and SPF mice had similar patterns of gut flora colonization, only CON-BALB/c mice had occasional circulating antibodies to mouse hepatitis virus and Sendai viruses. Maintenance in strict SPF conditions, therefore, results in a prolonged state of relative Ag deprivation and a failure to continuously activate new T and B cell populations. The results suggest that PCT formation depends on exogenous antigenic stimulation and that the presence of minimal gut flora is insufficient to render these mice susceptible to PCT induction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682379

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Pristane-induced arthritis is CD4+ T-cell dependent.

Authors:  L M Stasiuk; M Ghoraishian; C J Elson; S J Thompson
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

2.  Role of interleukin-6 in the pathogenesis of murine plasmacytoma and human multiple myeloma.

Authors:  P K Pattengale
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

3.  Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models.

Authors:  M Mittelman; D Neumann; A Peled; P Kanter; N Haran-Ghera
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 4.  Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.

Authors:  Timothy R Rosean; Van S Tompkins; Guido Tricot; Carol J Holman; Alicia K Olivier; Fenghuang Zhan; Siegfried Janz
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

5.  Translocation of an antibody transgene requires AID and occurs by interchromosomal switching to all switch regions except the mu switch region.

Authors:  Maryam Shansab; Jennifer M Eccleston; Erik Selsing
Journal:  Eur J Immunol       Date:  2011-04-11       Impact factor: 5.532

6.  A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas.

Authors:  Anne Tuomisto; Malin Sund; Jenni Tahkola; Anne Latvanlehto; Eeva-Riitta Savolainen; Helena Autio-Harmainen; Annikki Liakka; Raija Sormunen; Jussi Vuoristo; Anne West; Riitta Lahesmaa; Herbert C Morse; Taina Pihlajaniemi
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

7.  Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic mice.

Authors:  R C Andrew Symons; Mark J Daly; Jane Fridlyand; Terence P Speed; Wendy D Cook; Steven Gerondakis; Alan W Harris; Simon J Foote
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-30       Impact factor: 11.205

8.  Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.

Authors:  Wan Cheung Cheung; Joong Su Kim; Michael Linden; Liangping Peng; Brian Van Ness; Roberto D Polakiewicz; Siegfried Janz
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

9.  Construction of a BALB/c congenic mouse, C.C3H-Lpsd, that expresses the Lpsd allele: analysis of chromosome 4 markers surrounding the Lps gene.

Authors:  S N Vogel; J S Wax; P Y Perera; C Padlan; M Potter; B A Mock
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors.

Authors:  D M Hilbert; M Y Shen; U R Rapp; S Rudikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.